Skip to main content
Equibles

BlackRock Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1364742 New York, NY
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2024 · filed Aug 13, 2024
Position Value
$9,989,474,999
+$809,688,237 QoQ
Shares Held
21,312,244
-3.0% QoQ
Ownership
8.41%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 92% Shared 0% None 8%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2024

BlackRock Inc. holds $54,091,702,062 across 441 Biotechnology names. VRTX ranks #1 (18.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page 		21,312,244 $9,989,474,999
2 REGN
Regeneron Pharmaceuticals, Inc.
 8,446,366 $8,877,384,047
3 MRNA
Moderna, Inc.
 25,562,321 $3,035,525,609
4 ALNY
Alnylam Pharmaceuticals, Inc.
 9,547,663 $2,320,082,109
5 BMRN
Biomarin Pharmaceutical Inc
 22,738,349 $1,872,048,264
6 SRPT
Sarepta Therapeutics, Inc.
 10,324,404 $1,631,255,832
7 INCY
Incyte Corp
 21,356,274 $1,294,617,319
8 TECH
BIO-TECHNE Corp
 14,987,870 $1,073,880,877

All Filings in VRTX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2024-06-30 $9,989,474,999 21,312,244
2024-03-31 $9,179,786,762 21,960,687
2023-12-31 $8,903,242,678 21,881,203
2023-09-30 $7,853,786,481 22,585,226
2023-06-30 $8,030,736,102 22,820,426
2023-03-31 $7,532,253,395 23,906,603
2022-12-31 $7,000,442,168 24,241,437
2022-09-30 $7,308,875,580 25,243,060
2022-06-30 $7,083,398,051 25,137,152
2022-03-31 $6,241,424,795 23,916,254
2021-12-31 $5,258,306,840 23,944,931
2021-09-30 $4,271,352,662 23,547,895
2021-06-30 $4,710,094,735 23,360,089
2021-03-31 $5,209,817,431 24,244,113
2020-12-31 $5,735,710,632 24,268,895
2020-09-30 $6,850,768,208 25,175,541
2020-06-30 $7,405,197,858 25,507,898
2020-03-31 $5,312,483,112 22,326,048